IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tang Capital Management LLC

Q1 2014 Holdings

Filed 2014-05-15 | 16 holdings | $12.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$12.4M182,30098.5%
Heron Therapeutics Inc(HRTX)COM427746102$61.3K4,408,9870.5%
PDL Biopharma IncNOTE 2.875% 2/15/1569329YAE4$40.2K$25,974,0000.3%
Salix Pharmaceuticals IncCOM795435106$31.1K300,0000.2%
Opko Health IncNOTE 3.0% 2/1/3368375NAA1$19.0K$14,000,0000.2%
Horizon Pharma IncCOM44047T109$15.1K1,000,0000.1%
Endocyte IncCOM29269A102$11.1K465,7630.1%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$8.3K435,8430.1%
Mannkind CorpCOM56400P201$7.2K1,800,0000.1%
Dendreon CorpCOM24823Q107$16655,5480.0%
LA Jolla Pharmaceutical Co(LJPC)COM503459604$12111,2190.0%
RXI Pharmaceuticals CorpCOM74979C303$7818,2450.0%
Ambit Biosciences CorpCOM02318X100$0460.0%